Fonar Corporation  

(Public, NASDAQ:FONR)   Watch this stock  
Find more results for FONR
+0.10 (0.43%)
Real-time:   1:43PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 23.01 - 23.66
52 week 9.10 - 23.85
Open 23.17
Vol / Avg. 30,419.00/68,415.00
Mkt cap 150.54M
P/E 10.85
Div/yield     -
EPS 2.16
Shares 6.05M
Beta 1.58
Inst. own 31%
Sep 12, 2016
Q4 2016 Fonar Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 10, 2016
Q3 2016 Fonar Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 20.84% 22.35%
Operating margin 22.00% 19.25%
EBITD margin - 23.81%
Return on average assets 19.17% 20.13%
Return on average equity 24.37% 37.90%
Employees 465 -
CDP Score - -


110 Marcus Dr
MELVILLE, NY 11747-4228
United States - Map
+1-631-6942929 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: medical equipment segment, and physician management and diagnostic services segment. The Company directly operates the medical equipment segment, and the physician management and diagnostic services segment's operations are conducted through its subsidiary Health Management Corporation of America (HMCA). HMCA provides management services, administrative services, billing and collection services, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. The Company's products include Upright MRI/Stand-Up MRI and Fonar 360.

Officers and directors

Raymond V. Damadian Chairman of the Board
Age: 79
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy R. Damadian President, Chief Executive Officer
Age: 44
Bio & Compensation  - Reuters
Claudette J. V. Chan Secretary, Director
Age: 77
Bio & Compensation  - Reuters
Charles N. O'Data Lead Independent Director
Age: 79
Bio & Compensation  - Reuters
Robert J. Janoff Independent Director
Age: 88
Bio & Compensation  - Reuters
Ronald G. Lehman Independent Director
Age: 39
Bio & Compensation  - Reuters